Investing.com - Collplant ADR reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Collplant ADR announced earnings per share of $-0.36 on revenue of $0.6M. Analysts polled by Investing.com anticipated EPS of $0.48 on revenue of $10.1M.
Collplant ADR shares are up 4.02% from the beginning of the year, still down 60.07% from its 52 week high of $23.49 set on June 23, 2021. They are outperforming the Nifty 50 which is down 6.82% from the start of the year.
Collplant ADR follows other major Healthcare sector earnings this month
Collplant ADR's report follows an earnings missed by Novo Nordisk ADR on April 29, who reported EPS of $0.881 on revenue of $5.96B, compared to forecasts EPS of $0.8828 on revenue of $5.96B.
Pfizer had beat expectations on May 3 with first quarter EPS of $1.62 on revenue of $25.66B, compared to forecast for EPS of $1.49 on revenue of $24.1B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar